$108.25
-1.09-1%
Last update: Nov 12, 4:23 PM
Kodiak Sciences Inc (KOD) Stock Price, Quote, News & History
KODNASDAQ
U.S. stocks fell Monday, while Kodiak Sciences surged 174% after positive Phase 3 eye disease trial results; several small caps also rallied.
You can purchase shares of Kodiak Sciences (NASDAQ:KOD) through any online brokerage.
Other companies in Kodiak Sciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Kodiak Sciences has a consensus price target of $55.73.
The stock price for Kodiak Sciences (NASDAQ: KOD) is $107 last updated November 12, 2026 at 4:23 PM EST.
There are no upcoming dividends for Kodiak Sciences.
Kodiak Sciences does not have any upcoming earnings scheduled.
There is no upcoming split for Kodiak Sciences.
Kodiak Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's...
